May 25, 2017 12:46 pm UTC| Business
NEW YORK, May 25, 2017 -- StoneCastle Financial Corp. (Nasdaq:BANX) ("StoneCastle Financial" or the "Company"), a closed-end investment company registered with the Securities and Exchange Commission ("SEC"), announced...
Corium Prices Follow-On Offering of Common Stock
May 25, 2017 12:43 pm UTC| Business
MENLO PARK, Calif., May 25, 2017 -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products,...
Corium Prices Follow-On Offering of Common Stock
May 25, 2017 12:42 pm UTC| Business
MENLO PARK, Calif., May 25, 2017 -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products,...
Corium Prices Follow-On Offering of Common Stock
May 25, 2017 12:42 pm UTC| Business
MENLO PARK, Calif., May 25, 2017 -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products,...
Corium Prices Follow-On Offering of Common Stock
May 25, 2017 12:42 pm UTC| Business
MENLO PARK, Calif., May 25, 2017 -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products,...
Corium Prices Follow-On Offering of Common Stock
May 25, 2017 12:42 pm UTC| Business
MENLO PARK, Calif., May 25, 2017 -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products,...
Corium Prices Follow-On Offering of Common Stock
May 25, 2017 12:42 pm UTC| Business
MENLO PARK, Calif., May 25, 2017 -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products,...